Please assess the completion status of the following clinical trial:

Trial Title: Study Evaluating Safety and Efficacy of Bazedoxifene/Conjugated Estrogens Combinations in Postmenopausal Women

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Generally healthy, postmenopausal women aged 40 - 75 years inclusive~* Intact uterus~* Last natural menstrual cycle (without exogenous hormone therapy) completed at least 12 consecutive months before screening~Exclusion Criteria:~* A history or active presence of thrombophlebitis, thrombosis or thromboembolic disorders~* A history or active presence of cerebrovascular accident, stroke, or transient ischemic attack~* A history or active presence of malignancy, or treatment for malignancy, within the previous 10 years~Additional criteria applies.

- Gender: FEMALE
- Minimum Age: 40 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- A (Type: EXPERIMENTAL): None
- B (Type: ACTIVE_COMPARATOR): None
- C (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).